These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 34160068)
1. Nonmalignant meningioma and vestibular schwannoma incidence trends in the United States, 2004-2017. Withrow DR; Devesa SS; Deapen D; Petkov V; Van Dyke AL; Adamo M; Armstrong TS; Gilbert MR; Linet MS Cancer; 2021 Oct; 127(19):3579-3590. PubMed ID: 34160068 [TBL] [Abstract][Full Text] [Related]
2. Epidemiology of meningiomas post-Public Law 107-206: The Benign Brain Tumor Cancer Registries Amendment Act. Dolecek TA; Dressler EV; Thakkar JP; Liu M; Al-Qaisi A; Villano JL Cancer; 2015 Jul; 121(14):2400-10. PubMed ID: 25872752 [TBL] [Abstract][Full Text] [Related]
3. Incidence of vestibular schwannomas in the United States. Kshettry VR; Hsieh JK; Ostrom QT; Kruchko C; Barnholtz-Sloan JS J Neurooncol; 2015 Sep; 124(2):223-8. PubMed ID: 26024654 [TBL] [Abstract][Full Text] [Related]
4. Italian cancer figures, report 2012: Cancer in children and adolescents. ; ; Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445 [TBL] [Abstract][Full Text] [Related]
5. Underreporting of Vestibular Schwannoma Incidence Within National Brain Tumor and Cancer Registries in the United States. Marinelli JP; Nassiri AM; Habermann EB; Lohse CM; Holton SJ; Carlson ML Otol Neurotol; 2021 Jul; 42(6):e758-e763. PubMed ID: 34111053 [TBL] [Abstract][Full Text] [Related]
6. Incidence of Benign Meningiomas in the United States: Current and Future Trends. Bhala S; Stewart DR; Kennerley V; Petkov VI; Rosenberg PS; Best AF JNCI Cancer Spectr; 2021 Jun; 5(3):. PubMed ID: 34250440 [TBL] [Abstract][Full Text] [Related]
7. Descriptive Epidemiology of Spinal Meningiomas in the United States. Kshettry VR; Hsieh JK; Ostrom QT; Kruchko C; Benzel EC; Barnholtz-Sloan JS Spine (Phila Pa 1976); 2015 Aug; 40(15):E886-9. PubMed ID: 25996535 [TBL] [Abstract][Full Text] [Related]
8. Incidence trends and survival analysis of atypical meningiomas: a population-based study from 2004 to 2018. Recker MJ; Kuo CC; Prasad D; Attwood K; Plunkett RJ J Neurooncol; 2022 Oct; 160(1):13-22. PubMed ID: 35819682 [TBL] [Abstract][Full Text] [Related]
9. Descriptive epidemiology of vestibular schwannomas. Propp JM; McCarthy BJ; Davis FG; Preston-Martin S Neuro Oncol; 2006 Jan; 8(1):1-11. PubMed ID: 16443943 [TBL] [Abstract][Full Text] [Related]
10. Descriptive epidemiology of World Health Organization grades II and III intracranial meningiomas in the United States. Kshettry VR; Ostrom QT; Kruchko C; Al-Mefty O; Barnett GH; Barnholtz-Sloan JS Neuro Oncol; 2015 Aug; 17(8):1166-73. PubMed ID: 26008603 [TBL] [Abstract][Full Text] [Related]
11. Changes in incidence trends of meningioma in Finland, 1990-2017: analysis of Finnish Cancer Registry data. Ekqvist O; Raitanen J; Auvinen A Acta Oncol; 2023 Sep; 62(9):994-1000. PubMed ID: 37669182 [TBL] [Abstract][Full Text] [Related]
12. Trends in intracranial meningioma incidence in the United States, 2004-2015. Lin DD; Lin JL; Deng XY; Li W; Li DD; Yin B; Lin J; Zhang N; Sheng HS Cancer Med; 2019 Oct; 8(14):6458-6467. PubMed ID: 31475482 [TBL] [Abstract][Full Text] [Related]
13. Nonmalignant and malignant meningioma incidence and survival in the elderly, 2005-2015, using the Central Brain Tumor Registry of the United States. Achey RL; Gittleman H; Schroer J; Khanna V; Kruchko C; Barnholtz-Sloan JS Neuro Oncol; 2019 Feb; 21(3):380-391. PubMed ID: 30295804 [TBL] [Abstract][Full Text] [Related]
14. Long-term mobile phone use and the risk of vestibular schwannoma: a Danish nationwide cohort study. Schüz J; Steding-Jessen M; Hansen S; Stangerup SE; Cayé-Thomasen P; Poulsen AH; Olsen JH; Johansen C Am J Epidemiol; 2011 Aug; 174(4):416-22. PubMed ID: 21712479 [TBL] [Abstract][Full Text] [Related]
15. Epidemiology of adult meningioma: Report from the Dutch Brain Tumour Registry (2000-2019). Ho VKY; Anten MM; Garst A; Bos EM; Snijders TJ; Eekers DBP; Seute T; Eur J Neurol; 2023 Oct; 30(10):3244-3255. PubMed ID: 37433563 [TBL] [Abstract][Full Text] [Related]
16. Susceptibility weighted imaging - a problem-solving tool in differentiation of cerebellopontine angle schwannomas and meningiomas. Mishra A; Thomas B; Kapilamoorthy TR Neuroradiol J; 2017 Jun; 30(3):253-258. PubMed ID: 28627983 [TBL] [Abstract][Full Text] [Related]
17. AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas. Bush ML; Oblinger J; Brendel V; Santarelli G; Huang J; Akhmametyeva EM; Burns SS; Wheeler J; Davis J; Yates CW; Chaudhury AR; Kulp S; Chen CS; Chang LS; Welling DB; Jacob A Neuro Oncol; 2011 Sep; 13(9):983-99. PubMed ID: 21778190 [TBL] [Abstract][Full Text] [Related]
18. Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis. Bachir S; Shah S; Shapiro S; Koehler A; Mahammedi A; Samy RN; Zuccarello M; Schorry E; Sengupta S Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445724 [TBL] [Abstract][Full Text] [Related]
19. Does where you live influence how your vestibular schwannoma is managed? Examining geographical differences in vestibular schwannoma treatment across the United States. Carlson ML; Glasgow AE; Grossardt BR; Habermann EB; Link MJ J Neurooncol; 2016 Sep; 129(2):269-79. PubMed ID: 27334903 [TBL] [Abstract][Full Text] [Related]